
Thyroid medication recalled after Chinese supplier fails inspection
pharmafile | August 20, 2018 | News story | Sales and Marketing | China, FDA, recall, thyroid, westminster
The Mississippi based manufacturer Westminster Pharmaceuticals is voluntarily recalling thyroid medications Levothyroxine and Liothyronine after the Chinese company Sichuan Friendly Pharmaceutical Co failed an FDA inspection.
Sichuan Pharmaceutical who supplied Westminster with an Active Pharmaceutical Ingredient (API) used in the production of certain thyroid medications were found to have deficiencies with Current Good Manufacturing Practices (cGMP) and thus could pose a risk to patient safety.
As of yet there have been no reported adverse events in relation to the medications. The fda warned that “Because these products may be used in the treatment of serious medical conditions, patients taking the recalled medicines should continue taking their medicine until they have a replacement product.”
Westminster has told its wholesalers to immediately stop distributing the medications involved while also making arrangements for already distributed products to be returned.
The recall comes as drug safety scandals have plagued Chinese manufacturers in recent months. While protests erupted in Beijing over Changsheng Biotechnology’s corrupt practices, regulators recalled Chinese produced valsartan after it was found that some batches may be contaminated with carcinogens.
Louis Goss
Related Content

Rethinking oncology trial endpoints with generalised pairwise comparisons
For decades, oncology trials have been anchored to a familiar set of endpoints. Overall survival …

Alto Neuroscience’s schizophrenia treatment granted FDA Fast Track designation
Alto Neuroscience has announced that its investigational treatment for cognitive impairment associated with schizophrenia (CIAS) …

FDA approves Moderna’s updated COVID-19 vaccines targeting new variant
The US Food and Drug Administration (FDA) has approved Moderna’s updated COVID-19 vaccines, Spikevax and …






